Search
for
Sort by
Research 31–60 of 122
- Canine Epidermal Neural Crest Stem Cells: Characterization and Potential as Therapy Candidate for a Large Animal Model of Spinal Cord Injury
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Cutaneous drug reactions
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Efficacy of Scalp Cooling combined with DHL-HisZnNa Lotion in the Prevention of Chemotherapy-Induced Alopecia in Patients with Breast Cancer
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Effects of local and systemic medications on eye health: Adverse reactions
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature
- Chemically Induced Hair Loss/Alopecia
- 130 Expression of nidogen1 in basal cell carcinoma
- 126 cAMP response element-binding protein 1 (CREB) is a β-catenin-regulated transcription factor in squamous cell carcinoma (SCC) cells
- Alopecia and drugs
- Index
- Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs)